Almirall, S.A. and GW Pharmaceuticals plc today announced that the health authorities in Spain have granted regulatory approval for Sativex® Oromucosal Spray as an add-on therapy for the treatment of moderate to severe spasticity due to Multiple Sclerosis (MS) in patients who have not responded adequately to other anti-spasticity medication. Prior to launch, Sativex® requires pricing and reimbursement approval from the Spanish Ministry of Health. This final approval process is expected to be completed during the 4th Quarter of 2010... [Read More]
More from this author:
Multiple Sclerosis: What Part Do Relapses Play In Severe Disability?
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Multiple Sclerosis Relapses and Severe Disability
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Neuronal and BBB damage induced by sera from patients with secondary progressive multiple sclerosis.
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Stress, Fear, Anxiety and MS
From the Web > About.com Multiple Sclerosis: Most Popular Article
From the Web > About.com Multiple Sclerosis: Most Popular Article
Puusepp's sign—Clinical significance of a forgotten pyramidal sign
From the Web > MedWorm: Multiple Sclerosis
From the Web > MedWorm: Multiple Sclerosis
Related Articles:
Regulatory T cells and inhibitory cytokines in autoimmunity.
From the Web > MedWorm: Multiple Sclerosis
Thymic Regulation of Autoimmune Disease by Accelerated Differentiation of Foxp3+ Regulatory T Cells through IL-7 Signaling Pathway.
From the Web > MedWorm: Multiple Sclerosis
IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8(+) T cells and decreases memory CD8(+) subset: A longitudinal 1-year study.
From the Web > MedWorm: Multiple Sclerosis
Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
From the Web > MedWorm: Multiple Sclerosis
Merck KGaA Receives Refuse To File Letter From FDA On Cladribine Tablets New Drug Application
From the Web > Multiple Sclerosis News From Medical News Today
